US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules USP

Reason CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Breckenridge Pharmaceutical, Inc NDC 51991-748-10 D-0387-2025
Class II · Moderate risk Ongoing

ChlorproMAZINE Hydrochloride Tablets

Reason CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7129-61 D-0366-2025
Class II · Moderate risk Ongoing

Levothyroxine Sodium Tablets

Reason Subpotent

Accord Healthcare, INC. NDC 16729-452-15 D-0397-2025
Class II · Moderate risk Ongoing

Levothyroxine Sodium Tablets

Reason Subpotent

Accord Healthcare, INC. NDC 16729-450-17 D-0396-2025
Class II · Moderate risk Ongoing

Levothyroxine Sodium Tablets

Reason Subpotent

Accord Healthcare, INC. NDC 16729-448-17 D-0395-2025
Class II · Moderate risk Ongoing

Levothyroxine Sodium Tablets

Reason Subpotent

Accord Healthcare, INC. NDC 16729-447-17 D-0394-2025
Class II · Moderate risk Ongoing

Testosterone Cypionate Injection

Reason cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Eugia US LLC NDC 55150-277-01 D-0363-2025
Class II · Moderate risk Ongoing

Wegovy

Reason Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Cardinal Health Inc. NDC 0169-4524-14 D-0393-2025
Class II · Moderate risk Ongoing

Kapsin Ointment

Reason CGMP Deviations

Apipharma D-0376-2025
Class II · Moderate risk Ongoing

Hemopropin Ointment

Reason CGMP Deviations

Apipharma D-0375-2025
Class II · Moderate risk Ongoing

chlorproMAZINE Hydrochloride Tablets

Reason CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Zydus Pharmaceuticals (USA) Inc NDC 70710-1129-1 D-0361-2025
Class II · Moderate risk Ongoing

Haloperidol Decanoate Injection

Reason Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Amerisource Health Services LLC NDC 68001-581-48 D-0369-2025
Class II · Moderate risk Ongoing

Haloperidol Decanoate Injection

Reason Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Amerisource Health Services LLC NDC 68001-581-41 D-0368-2025
Class II · Moderate risk Ongoing

Haloperidol Decanoate Injection

Reason Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Amerisource Health Services LLC NDC 68001-580-41 D-0367-2025
Class II · Moderate risk Ongoing

Rocuronium Bromide 50 mg per 5mL

Reason Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health D-0374-2025
Class II · Moderate risk Ongoing

Ketamine HCl 50mg per 5mL

Reason Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health D-0373-2025
Class II · Moderate risk Ongoing

PHENYLephrine HCl in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health D-0372-2025
Class II · Moderate risk Ongoing

dexmedeTOMIDine HCl PF

Reason Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health D-0371-2025
Class II · Moderate risk Ongoing

Glycopyrrolate

Reason Lack of Assurance of Sterility: Leaking/damaged syringes.

Denver Solutions, LLC DBA Leiters Health NDC 71449-104-11 D-0370-2025
Class II · Moderate risk Ongoing

Unisom

Reason CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit

Chattem Inc D-0362-2025
Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules

Reason CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.

Breckenridge Pharmaceutical, Inc. NDC 51991-747-10 D-0308-2025
Class II · Moderate risk Ongoing

Clindamycin HCl

Reason CGMP Deviations

RemedyRepack Inc. D-0378-2025
Class II · Moderate risk Ongoing

Haloperidol Decanoate Injection

Reason Lack of Assurance of Sterility: Media fill with bacterial contamination

Somerset Therapeutics Private Limited NDC 70069-383-10 D-0358-2025
Class II · Moderate risk Ongoing

Haloperidol Decanoate Injection 100mg/mL

Reason Lack of Assurance of Sterility: Media fill with bacterial contamination

Somerset Therapeutics Private Limited NDC 68001-581-41 D-0357-2025